Serum Follistatin Levels are Independently Associated with Exercise Tolerance in Patients with Obesity

Hepatic follistatin increases basal metabolic rate and attenuates diet-induced obesity during hepatic insulin resistance

(2023) Rongya Tao et al.   Molecular Metabolism

Investigation of Brain Function-Related Myokine Secretion by Using Contractile 3D-Engineered Muscle

(2022) Takeshi Sugimoto et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Myostatin: A Skeletal Muscle Chalone

(2022) Se-Jin Lee   Annual Review of Physiology

Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis

(2022) Jessica Zannoni et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway

(2022) Junlu Tong et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Association of serum adiponectin and myostatin levels with skeletal muscle in patients with obesity: A cross-sectional study

(2021) Satoshi Kurose et al.   PLoS One

Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study

(2021) Giovanni Tarantino et al.   Journal of Clinical Medicine

Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People

(2021) Remigiusz Domin et al.   International Journal of Environmental Research and Public Health

The relationship between changes in serum myostatin and adiponectin levels in patients with obesity undergoing a weight loss program

(2021) Nana Takao et al.   BMC Endocrine Disorders

Elevated circulating follistatin associates with an increased risk of type 2 diabetes

(2021) Chuanyan Wu et al.   Nature Communications

Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women

(2021) Yanping Du et al.   BMC Geriatrics

Circulating follistatin and activin A and their regulation by insulin in obesity and type 2 diabetes

(2020) Lykke Sylow et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Modification of Muscle-Related Hormones in Women with Obesity: Potential Impact on Bone Metabolism

(2020) Laurent Maïmoun et al.   Journal of Clinical Medicine

Identification of frailty and sarcopenia in hospitalised older people

(2020) Iñaki Echeverria et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Mechanisms involved in follistatin‐induced hypertrophy and increased insulin action in skeletal muscle

(2019) Xiuqing Han et al.   Journal of Cachexia Sarcopenia and Muscle

Alterations in activin A–myostatin–follistatin system associate with disease activity in inflammatory myopathies

(2019) Lucia Vernerová et al.   RHEUMATOLOGY

Physiology of activins/follistatins: associations with metabolic and anthropometric variables and response to exercise

(2018) Nikolaos Perakakis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men

(2018) Elizaveta Fife et al.   BMC Geriatrics

Increased follistatin associated with decreased gait speed among old adults

(2016) Fang-Yih Liaw et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice

(2016) João-Paulo G. Camporez et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues

(2015) J Dong et al.   INTERNATIONAL JOURNAL OF OBESITY

Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review

(2014) Thomas A. White et al.   GERONTOLOGY

Skeletal Muscle Is an Endocrine Organ

(2014) Kenji Iizuka et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

The Epidemiology of Obesity: A Big Picture

(2014) Adela Hruby et al.   PHARMACOECONOMICS

Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling

(2013) Y. Zhang et al.   DIABETES

Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential

(2013) H.Q. Han et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Prognotic impact of serum follistatin in patients with hepatocellular carcinoma

(2013) Takeshi Tomoda et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome

(2012) M.-J. Chen et al.   HUMAN REPRODUCTION

Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease

(2011) Liping Zhang et al.   FASEB JOURNAL

Body Mass Index and Risk of Stroke and Myocardial Infarction in a Relatively Lean Population

(2010) Hiroshi Yatsuya et al.  

Myostatin Decreases with Aerobic Exercise and Associates with Insulin Resistance

(2010) DUSTIN S. HITTEL et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

Regulation of Muscle Mass by Follistatin and Activins

(2010) Se-Jin Lee et al.   MOLECULAR ENDOCRINOLOGY

Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase

(2009) V. B. Matthews et al.   DIABETOLOGIA

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET